Home › Funds › WEYBOSSET RESEARCH & MANAGEMENT LLC › BHVN
WEYBOSSET RESEARCH & MANAGEMENT LLC position in BHVN
BIOHAVEN LTD · Health Care
WEYBOSSET RESEARCH & MANAGEMENT LLC reported holding 20,000 shares of BHVN (BIOHAVEN LTD) in its Q3 2026 13F filing — a position valued at US$267K, representing 0.08% of its reported portfolio and ranking #31 among its reported holdings. WEYBOSSET RESEARCH & MANAGEMENT LLC has disclosed BHVN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How WEYBOSSET RESEARCH & MANAGEMENT LLC's BHVN position evolved
WEYBOSSET RESEARCH & MANAGEMENT LLC first disclosed a stake in BHVN in Q3 2023 at 12,140 shares (US$316K). The position peaked in Q1 2024 at 13,640 shares, worth US$5.1M. Across 13 filings, WEYBOSSET RESEARCH & MANAGEMENT LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 20,000 shares valued at US$267K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 12.14K | $316.00K | New |
| Q4 2023 | 13.64K | $583.79K | Add |
| Q1 2024 | 13.64K | $5.08M | Hold |
| Q2 2024 | 11.01K | $382.00K | Reduce |
| Q3 2024 | 11.01K | $550.00K | Hold |
| Q4 2024 | 13.64K | $510.00K | Add |
| Q1 2025 | 16.88K | $405.80K | Add |
| Q2 2025 | 19.28K | $272.04K | Add |
| Q3 2025 | 22.94K | $344.33K | Add |
| Q4 2025 | 22.99K | $259.56K | Hold |
| Q1 2026 | 22.99K | $194.50K | Hold |
| Q2 2026 | 20.00K | $297.60K | Reduce |
| Q3 2026 | 20.00K | $267.00K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BHVN and 13F data
BHVN (BIOHAVEN LTD) is a Health Care company. 30 other funds we track also report a position in BHVN — the largest reported positions include MONTANOVA CAPITAL, LLC (US$153.1M), INFINITUM ASSET MANAGEMENT, LLC (US$93.0M), Royalty Pharma Sub-Manager, LLC (US$43.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BHVN
- MONTANOVA CAPITAL, LLC 10.29M sh · $153.07M · Q2 2026
- INFINITUM ASSET MANAGEMENT, LLC 6.25M sh · $93.00M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 2.94M sh · $43.70M · Q2 2026
- Cormorant Asset Management, LP 2.61M sh · $38.84M · Q2 2026
- Knoll Capital Management, LLC 2.35M sh · $35.01M · Q2 2026
- TCG Crossover Management, LLC 1.78M sh · $26.49M · Q2 2026
- ARS Investment Partners, LLC 1.37M sh · $20.45M · Q2 2026
More on WEYBOSSET RESEARCH & MANAGEMENT LLC
FAQ
How long has WEYBOSSET RESEARCH & MANAGEMENT LLC held BHVN?
WEYBOSSET RESEARCH & MANAGEMENT LLC has disclosed BHVN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is WEYBOSSET RESEARCH & MANAGEMENT LLC's current position in BHVN?
As of Q3 2026, WEYBOSSET RESEARCH & MANAGEMENT LLC holds 20.00K shares of BHVN (BIOHAVEN LTD), valued at $267.00K, representing 0.08% of its reported portfolio and ranking #31.
Has WEYBOSSET RESEARCH & MANAGEMENT LLC been buying or selling BHVN?
In the latest 13F filing (Q3 2026), WEYBOSSET RESEARCH & MANAGEMENT LLC held unchanged its position in BHVN. The position peaked in Q1 2024 at 13.64K shares.
Which other funds hold BHVN?
Other major institutional holders of BHVN include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Royalty Pharma Sub-Manager, LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.